Baxter International warned on Friday that hurricane-related disruptions at its North Carolina IV solutions facility could affect its financials through early 2025. Shares of the medical products ...

Read about Baxter's progress in restoring its North Cove facility after Hurricane Helene-related flooding, causing widespread shortages and a $200 million loss.

Now Baxter said it expects to restart a second IV solutions manufacturing line in the coming week. "Together with the line ...

Baxter International cut its annual profit forecast on Friday, citing hurricane-related disruptions at its North Carolina intravenous solutions facility, causing its shares to fall 1.3% in premarket ...

First randomized placebo-controlled trial in NTM abscessusSymptom-based endpoints showed favorable improvement in frequency and severity of the most common symptomsMicrobiologic endpoints showed ...

Baxter expects to restart a second IV solutions manufacturing line within the next week, the company announced today. Along ...

Experts warn of continued IV fluid shortage as gray market manufacturers engage in price gouging. Baxter restarts some production after Hurricane Helene.

Severe damage from Hurricane Helene shut down a plant that has produced 60% of the IV bag solution used in hospitals across ...

the line represented roughly a quarter of the site’s total production and about half of the site’s production of 1-liter IV ...

Baxter announced Oct. 31 that it has restarted the highest-throughput IV solutions manufacturing line at its North Cove, N.C.

The nationwide shortage was sparked by damage to a major production facility in North Carolina from Hurricane Helene.

Baxter, which makes around 60% of the IV solutions used in the US daily, announced that it has restarted its ...